This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Carbohydrate-deficient Glycoprotein Syndrome Type I
Information about Carbohydrate-deficient Glycoprotein Syndrome Type I: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Carbohydrate-deficient Glycoprotein Syndrome Type I
Most recent studies have shown that Carbohydrate-deficient Glycoprotein Syndrome Type I shares some biological mechanisms with acquired-kyphosis, ataxia, atrophy, blood-coagulation-disorders, cardiomyopathies, cerebellar-ataxia, congenital-cerebellar-hypoplasia, congenital-disorders, congenital-disorders-of-glycosylation, dysequilibrium-syndrome, failure-to-thrive, hemorrhage, hydrops-fetalis, hypoplasia, metabolic-diseases, multisystem-disorder, muscle-hypotonia, nervousness, strabismus.
Among the many pathways, these few ones have gauged particular interests from scientists studying Carbohydrate-deficient Glycoprotein Syndrome Type I, and have been seen in publications frequently: Blood Coagulation, Coagulation, Fibrinolysis, Glycosylation, Intracellular Transport, Localization, Macrophage Activation, Nervous System Development, Pathogenesis, Protein Glycosylation, Reflex, S Phase, Secretion, System Development, Transport
Quite a number of genes have been found to play important roles in Carbohydrate-deficient Glycoprotein Syndrome Type I, such as AHCY, ALG1, CANX, CLU, DCN, ERG, GDI1, KCNH2, MPI, PMM1, PMM2, RET, SERPINA7, SERPINC1, TF, VLDLR. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.